The table below shows ABBOTT LABORATORIES's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$44.33B
$41.95B
$40.11B
$43.65B
$43.08B
$34.61B
Cost of revenue
$19.32B
$18.71B
$17.98B
$19.14B
$18.54B
$15.00B
Gross profit
-
-
-
-
-
-
R&D
$2.94B
$2.84B
$2.74B
$2.89B
$2.74B
$2.42B
SG&A
ABT annual revenue (10-K history)
ABBOTT LABORATORIES reported annual revenue of $44.33B for fiscal year 2025. That is up 5.7% from $41.95B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $20.85B (FY 2016) to $44.33B. Figures come from the company's audited annual reports as filed with the SEC.
